BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/28/2026 9:28:58 AM | Browse: 24 | Download: 3
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 124094
DOI 10.4251/wjgo.124094
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and systemic immune-inflammation index predict survival in HER2-negative advanced gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Xin Zheng, Jing Chen and Meng-Ting Li
Funding Agency and Grant Number
Corresponding Author Xin Zheng, Chief Physician, Clinical Laboratory, Laboratory Department, Chuzhou Hospital Affiliated to Anhui Medical University (Chuzhou First People's Hospital), Chuzhou 239000, Anhui China, Department of Laboratory Medicine, Chuzhou Hospital Affiliated to Anhui Medical University (Chuzhou First People’s Hospital), 369 Zuiweng West Road, Nanqiao District, Chuzhou City, Anhui Province, Chuzhou 239000, Anhui Province, China. sunnyacmilan@163.com
Key Words Inflammatory markers; HER2-negative; Advanced gastric cancer; Survival outcomes; Predictive value
Core Tip This retrospective cohort study of 262 patients with human epidermal growth factor receptor 2-negative advanced gastric cancer demonstrates that pretreatment peripheral blood neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and systemic immune-inflammation index (SII) are independent predictors of overall survival. Elevated NLR, PLR, and SII were risk factors, while elevated LMR was protective. The combined four marker nomogram achieved an area under the curve of 0.764, offering a simple, cost-effective tool for early risk stratification and treatment optimization in this population.
Citation Zheng X, Chen J, Li MT. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and systemic immune-inflammation index predict survival in HER2-negative advanced gastric cancer. World J Gastrointest Oncol 2026; In press
PDF 124094-in-press.pdf
Received
2026-06-05 11:36
Peer-Review Started
2026-06-05 11:37
First Decision by Editorial Office Director
Return for Revision
2026-06-22 02:14
Revised
2026-06-30 08:58
Publication Fee Transferred
2026-07-08 02:09
Second Decision by Editor
2026-08-28 02:55
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-08-28 09:28
Articles in Press
2026-08-28 09:28
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com